Rafferty Asset Management, LLC

Position in ORIC — Oric Pharmaceuticals, Inc.

CIK 1389426 New York, NY

Position in ORIC

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$982,963

-$480,168 QoQ

Shares Held

90,763

-21.4% QoQ

Ownership

0.088%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#79

of 179 holders

Holding Since

Mar 2021

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Rafferty Asset Management, LLC holds $331,711,589 across 163 Biotechnology names. ORIC ranks #89 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	65,798	$32,683,840
2	REGN	Regeneron Pharmaceuticals, Inc.	38,534	$24,027,490
3	ALNY	Alnylam Pharmaceuticals, Inc.	55,332	$16,656,591
4	MRNA	Moderna, Inc.	111,906	$7,836,777
5	INCY	Incyte Corp	44,663	$5,062,997
6	APGE	Apogee Therapeutics, Inc.	33,369	$4,429,067
7	ORKA	Oruka Therapeutics, Inc.	43,110	$4,102,778
8	KYMR	Kymera Therapeutics, Inc.	35,287	$4,046,360

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$982,963	90,763	-21.4%	Shares	Sole	2026-08-14
2026-03-31	$1,463,131	115,480	-34.8%	Shares	Sole	2026-05-15
2025-12-31	$1,449,324	177,179	+107.0%	Shares	Sole	2026-02-13
2025-09-30	$1,027,104	85,592	+100.7%	Shares	Sole	2025-11-12
2025-06-30	$432,836	42,644	-44.9%	Shares	Sole	2025-08-14
2025-03-31	$432,025	77,424	+50.7%	Shares	Sole	2025-05-14
2024-12-31	$414,733	51,392	-20.4%	Shares	Sole	2025-02-14
2024-09-30	$661,996	64,585	-44.4%	Shares	Sole	2024-11-13
2024-06-30	$821,590	116,208	+4.6%	Shares	Sole	2024-08-13
2024-03-31	$1,528,257	111,146	+62.4%	Shares	Sole	2024-05-13
2021-12-31	$1,005,818	68,423	+118.5%	Shares	Sole	2022-02-10
2021-09-30	$654,713	31,311	-34.3%	Shares	Sole	2021-11-10
2021-06-30	$842,645	47,634	-29.3%	Shares	Sole	2021-08-10
2021-03-31	$1,650,418	67,364	—	Shares	Sole	2021-05-10
No filing history on record for this holder in this stock.